Global Project Head, Solid Tumor Antibody Drug Conjugates (ADCs)

优缺点分析

角色解读

• Advance to broader global leadership roles such as Vice President of Oncology Development or Head of a Therapeutic Area.
• Move into senior executive positions in R&D strategy or become Chief Medical Officer at a biotech or pharma company.
• Expand impact by leading multiple assets or therapeutic franchises, potentially moving into commercial or corporate strategy roles.
• Lead the global clinical development strategy for a late-stage ADC in solid tumors, defining the compound's development plan and lifecycle management.
• Chair the Global Product Team (GPT) and align cross-functional efforts including translational, regulatory, manufacturing, safety, medical, and commercial teams.
• Serve as the Clinical Development representative on the Global Brand Team (GBT), ensuring alignment between development and commercial strategy.
• Engage with health authorities, external investigators, and advisory boards to drive regulatory submissions and trial designs.
• Deep expertise in solid tumor oncology clinical development, with at least 7 years industry experience.
• Proven leadership in managing high-performing cross-functional teams in a matrix environment.
• Strong understanding of global drug development regulations and successful track record of marketing authorization submissions.
• Excellent communication and interpersonal skills to influence internal and external stakeholders across cultures.

申请策略

• Tailor your cover letter to demonstrate alignment with Sanofi's mission of 'chasing the miracles of science' and your passion for advancing cancer care.
• Be prepared to discuss your leadership philosophy and specific examples of how you've driven high-performing teams in complex global settings.
• Emphasize your experience leading pivotal solid tumor trials that resulted in regulatory approvals, including specific examples of interactions with health authorities (FDA, EMA).
• Showcase your leadership of cross-functional teams, especially in matrix environments, with quantified outcomes (e.g., on-time enrollment, budget management).
• Highlight any experience with ADCs or antibody-based therapies, as well as biomarker-driven development strategies.
• Deepen your understanding of AI-powered drug development tools and digital biomarkers, as Sanofi emphasizes AI in R&D.
• Familiarize yourself with the latest regulatory guidance for ADCs and combination therapies in oncology.

面试指南

• Use the STAR method (Situation, Task, Action, Result) for behavioral questions, emphasizing the outcome and lessons learned.
• For strategic questions, outline a structured approach: assess the asset, identify key risks, define milestones, and propose a risk mitigation plan with stakeholder alignment.
• Describe how you would develop the global clinical strategy for a late-stage ADC in solid tumors.
• Give an example of a challenging cross-functional team conflict you resolved and how you achieved alignment.
• How have you interacted with regulatory authorities (e.g., FDA, EMA) during a submission or inspection?
• What is your approach to balancing commercial input with scientific rigor in clinical development?
• Describe a time you had to adapt a development plan based on new data or external landscape changes.
• Review Sanofi's ADC pipeline, particularly in solid tumors, and recent publications or presentations from their oncology team.